Literature DB >> 23930101

Computational modeling of cellular effects post-irradiation with low- and high-let particles and different absorbed doses.

Adriana Alexandre S Tavares1, João Manuel R S Tavares.   

Abstract

The use of computational methods to improve the understanding of biological responses to various types of radiation is an approach where multiple parameters can be modelled and a variety of data is generated. This study compares cellular effects modelled for low absorbed doses against high absorbed doses. The authors hypothesized that low and high absorbed doses would contribute to cell killing via different mechanisms, potentially impacting on targeted tumour radiotherapy outcomes. Cellular kinetics following irradiation with selective low- and high-linear energy transfer (LET) particles were investigated using the Virtual Cell (VC) radiobiology algorithm. Two different cell types were assessed using the VC radiobiology algorithm: human fibroblasts and human crypt cells. The results showed that at lower doses (0.01 to 0.2 Gy), all radiation sources used were equally able to induce cell death (p>0.05, ANOVA). On the other hand, at higher doses (1.0 to 8.0 Gy), the radiation response was LET and dose dependent (p<0.05, ANOVA). The data obtained suggests that the computational methods used might provide some insight into the cellular effects following irradiation. The results also suggest that it may be necessary to re-evaluate cellular radiation-induced effects, particularly at low doses that could affect therapeutic effectiveness.

Entities:  

Keywords:  Auger electrons; alpha particles; beta particles; bystander effect; cell kinetics; computational methods; radiation-induced effects; targeted tumour radiotherapy

Year:  2012        PMID: 23930101      PMCID: PMC3682197          DOI: 10.2203/dose-response.11-049.Tavares

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  36 in total

Review 1.  Molecular targeting with radionuclides: state of the science.

Authors:  Scott H Britz-Cunningham; S James Adelstein
Journal:  J Nucl Med       Date:  2003-12       Impact factor: 10.057

Review 2.  Evidence for 'bystander effects' in vivo.

Authors:  Antone L Brooks
Journal:  Hum Exp Toxicol       Date:  2004-02       Impact factor: 2.903

3.  Residual DNA damage: what is left over and how does this determine cell fate?

Authors:  T J McMillan
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

4.  Auger electrons: lethal, low energy, and coming soon to a tumor cell nucleus near you.

Authors:  C Andrew Boswell; Martin W Brechbiel
Journal:  J Nucl Med       Date:  2005-12       Impact factor: 10.057

5.  A review: Development of a microdose model for analysis of adaptive response and bystander dose response behavior.

Authors:  Bobby E Leonard
Journal:  Dose Response       Date:  2008-02-27       Impact factor: 2.658

6.  Ionizing radiation induces DNA double-strand breaks in bystander primary human fibroblasts.

Authors:  Mykyta V Sokolov; Lubomir B Smilenov; Eric J Hall; Igor G Panyutin; William M Bonner; Olga A Sedelnikova
Journal:  Oncogene       Date:  2005-11-10       Impact factor: 9.867

7.  Evaluating 99mTc Auger electrons for targeted tumor radiotherapy by computational methods.

Authors:  Adriana Alexandre S Tavares; João Manuel R S Tavares
Journal:  Med Phys       Date:  2010-07       Impact factor: 4.071

8.  Mechanisms of suppression of neoplastic transformation in vitro by low doses of low LET radiation.

Authors:  M C Pant; X-Y Liao; Q Lu; S Molloi; E Elmore; J L Redpath
Journal:  Carcinogenesis       Date:  2003-09-26       Impact factor: 4.944

9.  Low-dose irradiation of nontransformed cells stimulates the selective removal of precancerous cells via intercellular induction of apoptosis.

Authors:  Daniel I Portess; Georg Bauer; Mark A Hill; Peter O'Neill
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

Review 10.  Radionuclide carriers for targeting of cancer.

Authors:  Stavroula Sofou
Journal:  Int J Nanomedicine       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.